Alkermes plc. Repayments of Long-Term Debt
Alkermes plc. (ALKS) reported Repayments of Long-Term Debt of $6.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-07-28
- Alkermes plc. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Alkermes plc. repayments of long-term debt for the quarter ending 2024-09-30 was $750.00K, a 0.00% change year-over-year.
- Alkermes plc. repayments of long-term debt for the quarter ending 2024-06-30 was $750.00K, a 0.00% change year-over-year.
- Alkermes plc. repayments of long-term debt for the quarter ending 2024-03-31 was $750.00K, a 0.00% change year-over-year.
- Alkermes plc. repayments of long-term debt for fiscal 2024 was $2.25M, a 25.00% decline from fiscal 2023.
- Alkermes plc. repayments of long-term debt for fiscal 2023 was $3.00M, a 0.00% change from fiscal 2022.
- Alkermes plc. repayments of long-term debt for fiscal 2022 was $3.00M, a 33.33% increase from fiscal 2021.
- Alkermes plc. repayments of long-term debt for fiscal 2021 was $2.25M, a 20.86% decline from fiscal 2020.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $6.63M 10-Q · filed 2026-07-28 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-28 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $750.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.50M derived: sum of 3 quarters · filed 2026-02-25 | $2.25M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.50M derived: sum of 2 quarters · filed 2025-10-28 | $2.25M 10-Q · filed 2025-10-28 | $3.00M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $1.50M 10-Q · filed 2025-07-29 | $2.25M derived: sum of 3 quarters · filed 2026-02-25 | $3.00M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | $750.00K 10-Q · filed 2025-05-01 | $1.50M derived: sum of 2 quarters · filed 2026-02-25 | $2.25M derived: sum of 3 quarters · filed 2026-02-25 | $3.00M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.50M derived: sum of 2 quarters · filed 2026-02-25 | $2.25M derived: sum of 3 quarters · filed 2026-02-25 | $3.00M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $1.50M derived: sum of 2 quarters · filed 2024-10-24 | $2.25M 10-Q · filed 2024-10-24 | $3.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $1.50M 10-Q · filed 2024-07-24 | $2.25M derived: sum of 3 quarters · filed 2025-02-12 | $3.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | $750.00K 10-Q · filed 2024-05-01 | $1.50M derived: sum of 2 quarters · filed 2025-02-12 | $2.25M derived: sum of 3 quarters · filed 2025-02-12 | $3.00M derived: sum of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.50M derived: sum of 2 quarters · filed 2025-02-12 | $2.25M derived: sum of 3 quarters · filed 2025-02-12 | $3.00M 10-K · filed 2025-02-12 | |
| 2022-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $1.50M derived: sum of 2 quarters · filed 2023-10-25 | $2.25M 10-Q · filed 2023-10-25 | $3.00M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $1.50M 10-Q · filed 2023-07-26 | $2.25M derived: sum of 3 quarters · filed 2024-02-21 | $3.00M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $750.00K 10-Q · filed 2023-04-26 | $1.50M derived: sum of 2 quarters · filed 2024-02-21 | $2.25M derived: sum of 3 quarters · filed 2024-02-21 | ||
| 2021-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.50M derived: sum of 2 quarters · filed 2024-02-21 | $2.25M 10-K · filed 2024-02-21 | ||
| 2021-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.50M 10-Q · filed 2022-11-02 | |||
| 2021-06-30 | $750.00K 10-Q · filed 2022-07-27 | ||||
| 2020-12-31 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.42M derived: sum of 2 quarters · filed 2023-02-16 | $2.13M derived: sum of 3 quarters · filed 2023-02-16 | $2.84M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $711.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $1.42M derived: sum of 2 quarters · filed 2021-10-27 | $2.13M 10-Q · filed 2021-10-27 | $2.84M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-06-30 | $710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $1.42M 10-Q · filed 2021-07-28 | $2.13M derived: sum of 3 quarters · filed 2022-02-16 | $2.84M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-03-31 | $711.00K 10-Q · filed 2021-04-28 | $1.42M derived: sum of 2 quarters · filed 2022-02-16 | $2.13M derived: sum of 3 quarters · filed 2022-02-16 | $2.84M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2019-12-31 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.42M derived: sum of 2 quarters · filed 2022-02-16 | $2.13M derived: sum of 3 quarters · filed 2022-02-16 | $2.84M 10-K · filed 2022-02-16 | |
| 2019-09-30 | $711.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.42M derived: sum of 2 quarters · filed 2020-10-29 | $2.13M 10-Q · filed 2020-10-29 | $1.45M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-06-30 | $710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $1.42M 10-Q · filed 2020-07-29 | $743.00K derived: sum of 3 quarters · filed 2021-02-11 | $1.45M derived: sum of 4 quarters · filed 2021-02-11 | |
| 2019-03-31 | $711.00K 10-Q · filed 2020-04-29 | $33.00K derived: sum of 2 quarters · filed 2021-02-11 | $744.00K derived: sum of 3 quarters · filed 2021-02-11 | ||
| 2018-12-31 | -$678.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $33.00K derived: sum of 2 quarters · filed 2021-02-11 | $743.00K 10-K · filed 2021-02-11 | $2.13M 10-K · filed 2019-02-15 | |
| 2018-09-30 | $711.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $1.42M 10-Q · filed 2019-10-23 | |||
| 2018-06-30 | $710.00K 10-Q · filed 2019-07-25 | ||||
| 2017-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $1.50M derived: sum of 2 quarters · filed 2019-02-15 | $2.25M derived: sum of 3 quarters · filed 2019-02-15 | $3.00M 10-K · filed 2019-02-15 | |
| 2017-09-30 | $750.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $1.50M derived: sum of 2 quarters · filed 2018-10-23 | $2.25M 10-Q · filed 2018-10-23 | -$59.38M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2017-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $1.50M 10-Q · filed 2018-07-26 | -$60.13M derived: sum of 3 quarters · filed 2019-02-15 | $1.55M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2017-03-31 | $750.00K 10-Q · filed 2018-04-26 | -$60.88M derived: sum of 2 quarters · filed 2019-02-15 | $804.00K derived: sum of 3 quarters · filed 2019-02-15 | $2.49M derived: sum of 4 quarters · filed 2019-02-15 | |
| 2016-12-31 | -$61.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $54.00K derived: sum of 2 quarters · filed 2019-02-15 | $1.74M derived: sum of 3 quarters · filed 2019-02-15 | $3.43M 10-K · filed 2019-02-15 | $65.81M 10-K · filed 2017-02-17 |
| 2016-09-30 | $61.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $63.38M derived: sum of 2 quarters · filed 2017-10-26 | $65.06M 10-Q · filed 2017-10-26 | $66.75M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $3.38M 10-Q · filed 2017-07-27 | $5.06M derived: sum of 3 quarters · filed 2018-02-16 | $6.75M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2016-03-31 | $1.69M 10-Q · filed 2017-04-27 | $3.37M derived: sum of 2 quarters · filed 2018-02-16 | $5.06M derived: sum of 3 quarters · filed 2018-02-16 | $6.75M derived: sum of 4 quarters · filed 2018-02-16 | |
| 2015-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $3.38M derived: sum of 2 quarters · filed 2018-02-16 | $5.06M derived: sum of 3 quarters · filed 2018-02-16 | $6.75M 10-K · filed 2018-02-16 | |
| 2015-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $3.38M derived: sum of 2 quarters · filed 2016-11-02 | $5.06M 10-Q · filed 2016-11-02 | $6.75M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $3.38M 10-Q · filed 2016-07-28 | $5.06M derived: sum of 3 quarters · filed 2017-02-17 | $6.75M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-03-31 | $1.69M 10-Q · filed 2016-04-28 | $3.37M derived: sum of 2 quarters · filed 2017-02-17 | $5.06M derived: sum of 3 quarters · filed 2017-02-17 | $6.75M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2014-12-31 | $1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $3.37M derived: sum of 2 quarters · filed 2017-02-17 | $5.06M derived: sum of 3 quarters · filed 2017-02-17 | $6.75M 10-K · filed 2017-02-17 | |
| 2014-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $3.38M derived: sum of 2 quarters · filed 2015-10-29 | $5.06M 10-Q · filed 2015-10-29 | $6.75M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $3.38M 10-Q · filed 2015-07-30 | $5.06M derived: sum of 3 quarters · filed 2016-02-25 | $6.75M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $1.69M 10-Q · filed 2015-04-30 | $3.37M derived: sum of 2 quarters · filed 2016-02-25 | $5.06M derived: sum of 3 quarters · filed 2016-02-25 | $6.75M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $1.69M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $3.37M derived: sum of 2 quarters · filed 2016-02-25 | $5.06M 10-K · filed 2016-02-25 | $6.75M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-09-30 | $1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | $3.38M 10-Q · filed 2013-10-31 | $7.14M 10-Q · filed 2014-10-29 | $6.75M derived: sum of 4 quarters · filed 2014-04-30 | |
| 2013-06-30 | $1.69M 10-Q · filed 2013-07-25 | $5.45M 10-Q · filed 2014-07-31 | $5.06M derived: sum of 3 quarters · filed 2014-04-30 | $450.86M derived: sum of 4 quarters · filed 2014-04-30 | |
| 2013-03-31 | $1.69M 10-Q · filed 2014-04-30 | $3.38M derived: sum of 2 quarters · filed 2014-04-30 | $449.17M derived: sum of 3 quarters · filed 2014-04-30 | $449.94M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $447.48M derived: sum of 2 quarters · filed 2013-10-31 | $448.26M 10-Q · filed 2013-01-31 | ||
| 2012-09-30 | $445.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | $446.57M 10-Q · filed 2013-10-31 | |||
| 2012-06-30 | $775.00K 10-Q · filed 2013-07-25 | ||||
| 2012-03-31 | $775.00K 10-KT · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |